Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 14, Number 6—June 2008
Dispatch

Ceftriaxone-Resistant Salmonella enterica Serotype Newport, France

Svetlana Egorova*1, Mohammed Timinouni*2, Marie Demartin*, Sophie A. Granier†, Jean M. Whichard‡, Vartul Sangal§, Laëtitia Fabre*, Aurélia Delauné*, Maria Pardos*, Yves Millemann¶, Emmanuelle Espié#, Mark Achtman§**, Patrick A.D. Grimont*, and François-Xavier Weill*Comments to Author 
Author affiliations: *Institut Pasteur, Paris, France; †Agence Française de Sécurité Sanitaire des Aliments, Maisons-Alfort, France; ‡Centers for Disease Control and Prevention, Atlanta, Georgia, USA; §Max-Planck-Institute für Infektionsbiologie, Berlin, Germany; ¶Ecole Nationale Vétérinaire d’Alfort, Maisons-Alfort, France; #Institut de Veille Sanitaire, Saint-Maurice, France; **University College, Cork, Ireland;

Main Article

Table

Resistance to specific antimicrobial drugs in Salmonella enterica serotype Newport from humans in France, 2000–2005*

Drug % Resistant isolates
2000 (n = 100) (N = 109) 2001 (n = 124) (N = 134) 2002 (n = 66) (N = 71) 2003 (n = 126) (N = 138) 2004 (n = 91) (N = 94) 2005 (n = 78) (N = 80)
Amoxicillin 27 9.7 1.5 19.8 8.8 3.8
Ceftriaxone/ceftazidime 15 4 1.5 17.5 2.2 0
Gentamicin 4 1.6 0 1.6 2.2 0
Nalidixic acid 23 7.3 4.5 1.6 4.4 2.6
Ciprofloxacin 0 0 0 0 0 0
Sulfonamides 29 10.5 4.5 19.8 8.8 0
Trimethoprim 10 4 3 1.6 4.4 0
Chloramphenicol 25 9.7 1.5 15.9 8.8 0
Tetracycline 27 11.3 3 19 9.9 3.8

*n, no. of isolates studied; N, no. of isolates received at the French National Reference Centre for Salmonella (1 per patient).

Main Article

1Current affiliation: Institut Pasteur, St. Petersburg, Russia.

2Current affiliation: Institut Pasteur, Casablanca, Morocco.

Page created: July 09, 2010
Page updated: July 09, 2010
Page reviewed: July 09, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external